Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

There are \ 85,000 lung cancer patients (LCPs) in the UK; yet only around 8% were recruited into clinical trials in 2021/22. LCPs need opportunities to take part in clinical trials to access new treatments, increasing their quality of life, treatment choices and life expectancy. Discussions with nurses can help patients make better treatment decisions, improving experiences of care. However, research has shown that lung cancer nurses (LCNs) often feel unable to discuss participation in trials with patients due to lack of knowledge, confidence, time and training. This study aims to develop and test a research recruitment tool for LCNs, to support LCPs to enter clinical trials. Objectives include to: * Explore reasons for low uptake of LCPs into clinical trials * Develop a tool for LCNs to talk to patients about clinical trials * Test whether the tool improves the number and quality of discussions nurses have with LCPs about clinical trials The study has four phases: Phase 1: A literature review will identify problems that make clinical trial uptake difficult for LCPs, carers and clinicians Phase 2: Six group discussions with LCNs, patients and carers will explore issues that create potential barriers for patients taking part in clinical trials. The groups will take place online, last approximately one hour and be recorded. Phase 3: Part 1\&2 findings will help us develop a LCN research recruitment tool. The tool will contain information on how nurses obtain information about LC clinical trials, research teams, communication issues, practical issues and how to reach LCPs. Phase 4: The research recruitment tool will be tested in four UK NHS hospitals. A survey will identify any changes in nurses' clinical trials awareness and confidence before and after using the tool. Interviews with LCNs, patients and carers will explore their views on the tool, clinical trials participation and experiences of care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Registered nurse with Nursing and Midwifery Council

• Actively involved in the clinical care pathways of lung cancer patients

• Working at one of the six participating NHS trusts

• Age between 18-65 years of age

Locations
Other Locations
United Kingdom
Faculty of Health and Life Sciences, Oxford Brookes University
RECRUITING
Oxford
Contact Information
Primary
Catherine L Henshall, PhD
chenshall@brookes.ac.uk
07778 428994
Backup
Iain Williamson, PhD
iwilliamson@dmu.ac.uk
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 36
Treatments
Intervention
Nurse participants will be provided with a research readiness tool to facilitate their discussions with lung cancer patients about clinical trial opportunities. The tool will be used by nurses over a six month period, alongside usual care.
Control
No intervention. Nurse participants will provide usual care to lung cancer patients.
Related Therapeutic Areas
Sponsors
Leads: Oxford Brookes University
Collaborators: De Montfort University

This content was sourced from clinicaltrials.gov